Search Results - "Vázquez Costa, Juan Francisco"

Refine Results
  1. 1
  2. 2

    Insights into phenotypic variability caused by GARS1 pathogenic variants by Jiménez‐Jiménez, Jesús, Navarrete, Irene, Azorín, Inmaculada, Martí, Pilar, Vílchez, Roger, Muelas, Nuria, Cabello‐Murgui, Javier, Millet, Elvira, VázquezCosta, Juan Francisco, Vílchez, Juan J., Sevilla, Teresa, Sivera, Rafael

    Published in European journal of neurology (01-10-2024)
    “…Background and Purpose Pathogenic variants of the glycyl‐tRNA synthetase 1 (GARS1) gene have been described as a cause of Charcot–Marie–Tooth disease type 2D,…”
    Get full text
    Journal Article
  3. 3

    Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study by Arlandis, Salvador, VázquezCosta, Juan Francisco, Martínez‐Cuenca, Esther, Sevilla, Teresa, Boronat, Francisco, Broseta, Enrique

    Published in Neurourology and urodynamics (01-03-2017)
    “…Aims To determine lower urinary tract symptoms (LUTS) prevalence and urodynamic findings in amyotrophic lateral sclerosis (ALS) patients treated in our…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Risdiplam in non‐sitter patients aged 16 years and older with 5q spinal muscular atrophy by Ñungo Garzón, Nancy Carolina, Pitarch Castellano, Inmaculada, Sevilla, Teresa, VázquezCosta, Juan Francisco

    Published in Muscle & nerve (01-05-2023)
    “…Introduction/Aims Risdiplam has been approved for the treatment of patients with 5q spinal muscular atrophy (SMA), but data from type 2 non‐sitter patients are…”
    Get full text
    Journal Article
  6. 6

    Pediatric inherited peripheral neuropathy: a prospective study at a Spanish referral center by Argente‐Escrig, Herminia, Frasquet, Marina, VázquezCosta, Juan Francisco, Millet‐Sancho, Elvira, Pitarch, Inmaculada, Tomás‐Vila, Miguel, Espinós, Carmen, Lupo, Vincenzo, Sevilla, Teresa

    “…Background Single‐center clinical series provide important information on genetic distribution that can guide genetic testing. However, there are few such…”
    Get full text
    Journal Article
  7. 7

    Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen by Andrés-Benito, Pol, Vázquez-Costa, Juan Francisco, Ñungo Garzón, Nancy Carolina, Colomina, María J, Marco, Carla, González, Laura, Terrafeta, Cristina, Domínguez, Raúl, Ferrer, Isidro, Povedano, Mónica

    “…The objective of this study is to evaluate biomarkers for neurodegenerative disorders in adult SMA patients and their potential for monitoring the response to…”
    Get full text
    Journal Article
  8. 8

    Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome by Vázquez-Costa, Juan Francisco, Payá-Montes, María, Martínez-Molina, Marina, Jaijo, Teresa, Szymanski, Jazek, Mazón, Miguel, Sopena-Novales, Pablo, Pérez-Tur, Jordi, Sevilla, Teresa

    Published in Frontiers in molecular neuroscience (30-08-2021)
    “…Primary lateral sclerosis (PLS) is a progressive upper motor neuron (UMN) disorder. It is debated whether PLS is part of the amyotrophic lateral sclerosis…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis by Mazón, Miguel, Vázquez Costa, Juan Francisco, Ten-Esteve, Amadeo, Martí-Bonmatí, Luis

    Published in Frontiers in neuroscience (25-10-2018)
    “…The term amyotrophic lateral sclerosis (ALS) comprises a heterogeneous group of fatal neurodegenerative disorders of largely unknown etiology characterized by…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Evaluation of the substantia nigra by means of transcranial ultrasound imaging by Vivo-Orti, María Nieves, Tembl, José Ignacio, Sastre-Bataller, Isabel, Vazquez-Costa, Juan Francisco, Sahuquillo, Patricia, Burguera, Juan Andrés

    Published in Revista de neurologiá (01-03-2013)
    “…AIM. To describe the prevalence of hyperechogenicity of the substantia nigra in two samples of patients: one group who had been diagnosed with Parkinson's…”
    Get full text
    Journal Article
  14. 14

    Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene by Frasquet, Marina, Lupo, Vincenzo, Chumillas, María José, Vázquez-Costa, Juan Francisco, Espinós, Carmen, Sevilla, Teresa

    Published in Journal of the neurological sciences (15-04-2018)
    “…PHARC (Polyneuropathy, Hearing loss, Ataxia, Retinitis pigmentosa and Cataracts) (MIM# 612674) is an autosomal recessive neurodegenerative disease caused by…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder by Vázquez-Costa, Juan Francisco, Arlandis, Salvador, Hervas, David, Martínez-Cuenca, Esther, Cardona, Fernando, Pérez-Tur, Jordi, Broseta, Enrique, Sevilla, Teresa

    Published in Journal of the neurological sciences (15-07-2017)
    “…Abstract Introduction Lower urinary tract symptoms (LUTS) are frequent in motor neuron disease (MND) patients, but clinical factors related to them are…”
    Get full text
    Journal Article
  17. 17

    Facial onset sensory and motor neuronopathy: a motor neuron disease with an oligogenic origin? by Vázquez-Costa, Juan Francisco, Pedrola Vidal, Laia, Moreau-Le Lan, Sarah, Teresí-Copoví, Irene, Frasquet, Marina, Chumillas, Maria J., Sevilla, Teresa

    “…Objective: To describe a patient with facial onset sensory and motor neuronopathy (FOSMN) carrying heterozygous mutations in both TARDBP and SQSTM1 genes…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Quantitative Muscle Ultrasonography Using Textural Analysis in Amyotrophic Lateral Sclerosis by Martínez-Payá, Jacinto Javier, Ríos-Díaz, José, del Baño-Aledo, María Elena, Tembl-Ferrairó, Jose Ignacio, Vazquez-Costa, Juan Francisco, Medina-Mirapeix, Francesc

    Published in Ultrasonic imaging (01-11-2017)
    “…The purpose of this study was to analyze differences in gray-level co-occurrence matrix (GLCM) parameters, as assessed by muscle ultrasound (MUS), between…”
    Get full text
    Journal Article